With a population of close to 4 billion, which is increasing at double digit rates, the region is poised for significant growth in the area of medical products. In addition, increased prosperity leads to a greater demand for quality healthcare, as the people are both able and willing to pay for better healthcare. It is predicted that within the next 3-5 years, Asia will spend $225 billion on healthcare, and an estimated 130 million Asians will be able to pay for private healthcare.
|
Furthermore, international travel has led to the emergence of the “global village”, giving an upside opportunity for product crossover to and from Western markets. These factors create significant opportunities for the private vaccine market. |